NASDAQ · AIRS
Healthcare · Medical - Care Facilities
$3.38
Up+$0.05 (+1.48%)
Updated Aug 15, 2026, 12:06 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
AIRS closed at $3.38 after 20 trading sessions, down 24.04% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $3.24 | $3.54 | $3.24 | $3.38 | 1.56M |
| Aug 12, 2026 | $3.22 | $3.315 | $2.9657 | $3.25 | 1.38M |
| Aug 11, 2026 | $2.96 | $3.398 | $2.84 | $3.215 | 2.24M |
| Aug 10, 2026 | $2.865 | $3.12 | $2.50 | $2.75 | 4.08M |
| Aug 7, 2026 | $4.78 | $5.20 | $4.78 | $5.01 | 714.89K |
| Aug 6, 2026 | $4.92 | $5.03 | $4.71 | $4.77 | 444.75K |
| Aug 5, 2026 | $4.895 | $5.04 | $4.89 | $4.95 | 260.04K |
| Aug 4, 2026 | $4.93 | $5.05 | $4.90 | $4.96 | 439.39K |
| Aug 3, 2026 | $4.81 | $4.92 | $4.68 | $4.88 | 220.76K |
| Jul 31, 2026 | $4.87 | $4.87 | $4.55 | $4.81 | 357.54K |
| Jul 30, 2026 | $4.44 | $4.92 | $4.43 | $4.85 | 329.2K |
| Jul 29, 2026 | $4.64 | $4.6551 | $4.3307 | $4.355 | 426.17K |
| Jul 28, 2026 | $4.69 | $4.6999 | $4.205 | $4.66 | 439.3K |
| Jul 27, 2026 | $4.69 | $4.81 | $4.51 | $4.69 | 303.78K |
| Jul 24, 2026 | $4.71 | $4.75 | $4.55 | $4.61 | 266.43K |
| Jul 23, 2026 | $4.71 | $4.80 | $4.62 | $4.67 | 310.34K |
| Jul 22, 2026 | $4.86 | $4.95 | $4.735 | $4.82 | 299.76K |
| Jul 21, 2026 | $5.02 | $5.10 | $4.81 | $4.86 | 458.31K |
| Jul 20, 2026 | $4.52 | $4.955 | $4.48 | $4.78 | 653.19K |
| Jul 17, 2026 | $4.10 | $4.565 | $4.10 | $4.45 | 619.65K |
The latest Smart Investors Daily articles mentioning AIRS.
AIRS research
Company profile and research snapshot.
AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. Elite Body Sculpture, provides custom body contouring using the proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure. The company has one operating and reportable segment, direct medical procedure services.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 31, 2025 | Leerink Partners | Market Perform | — |
| Jan 17, 2025 | Piper Sandler | Neutral | — |
| Jan 6, 2025 | Piper Sandler | Neutral | — |
| Oct 17, 2024 | BTIG | Neutral | — |
| May 14, 2024 | Leerink Partners | Market Perform | — |
No generated briefing is available yet.
SeekingAlpha · Aug 10, 2026
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call August 10, 2026 8:30 AM EDTCompany ParticipantsYogesh Jashnani - CEO & DirectorMichael Arthur...
Benzinga · Aug 10, 2026
AirSculpt Technologies (NASDAQ:AIRS) narrows FY2026 sales outlook from $151.000 million-$157.000 million to $151.000 million vs $153.185 million estimate.
Benzinga · Jul 31, 2026
U.S. stock futures rise, Nasdaq 100 up 300 points. Apple Inc shares fall 7.4% despite beating analyst estimates for Q3. Other stocks also dip in pre-market.
prnewswire.com · Nov 18, 2025
Allowing customers to safely accelerate AI agent adoption across the enterprise while removing security roadblocks SANTA CLARA, Calif. , Nov. 18, 2025 /PRNewswire/ -- In today's enterprise, the adoption of AI agents is increasing dramatically, with production numbers projected to hit 1.3 billion by 2028.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AIRS.
